New injection could shrink heart attack scarring
NCT ID NCT07306182
First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 24 times
Summary
This study tests a new medicine called SGC001 in 210 people having a heart attack (anterior STEMI) and scheduled for a procedure to open blocked arteries (pPCI). The drug aims to reduce heart muscle damage and inflammation, potentially preventing future heart problems. Participants receive either SGC001 or a placebo by IV once, and researchers compare outcomes like heart scar size and function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linfen Central Hospital
RECRUITINGLinfen, Shanxi, 041099, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.